Current status of treatment for colorectal liver metastases in the United Kingdom.
作者信息
Okamoto Kentaro, Uetake Hiroyuki
机构信息
Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
出版信息
Hepatobiliary Surg Nutr. 2021 Jan;10(1):116-118. doi: 10.21037/hbsn.2020.04.08.
Abstract
摘要
相似文献
1
Current status of treatment for colorectal liver metastases in the United Kingdom.英国结直肠癌肝转移的治疗现状
Hepatobiliary Surg Nutr. 2021 Jan;10(1):116-118. doi: 10.21037/hbsn.2020.04.08.
2
Hepatic resection for colorectal metastases - a national perspective.结直肠癌肝转移的肝切除术——全国视角
Ann R Coll Surg Engl. 2004 Nov;86(6):420-4. doi: 10.1308/147870804696.
3
Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial.肝切除手术与热消融治疗结直肠癌肝转移（LAVA）：一项随机对照试验的研究方案
Trials. 2018 Feb 13;19(1):105. doi: 10.1186/s13063-018-2499-5.
4
Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.复发性结直肠癌肝转移的根治性治疗：消融与切除的比较
Eur J Surg Oncol. 2017 Oct;43(10):1901-1907. doi: 10.1016/j.ejso.2017.08.008. Epub 2017 Aug 26.
5
Transarterial chemoembolization (TACE) for colorectal liver metastases--current status and critical review.经动脉化疗栓塞术（TACE）治疗结直肠癌肝转移——现状与批判性综述
Langenbecks Arch Surg. 2015 Aug;400(6):641-59. doi: 10.1007/s00423-015-1308-9. Epub 2015 Jun 19.
6
Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases.结直肠癌肝转移切除术后的术前全身炎症与感染性并发症
Arch Surg. 2011 Apr;146(4):471-8. doi: 10.1001/archsurg.2011.50.
7
Microwave ablation with or without resection for colorectal liver metastases.微波消融联合或不联合切除术治疗结直肠肝转移瘤。
Eur J Surg Oncol. 2013 Aug;39(8):844-9. doi: 10.1016/j.ejso.2013.04.005. Epub 2013 Jun 14.
8
Current Treatment of Colorectal Liver Metastasis as a Chronic Disease.结直肠癌肝转移的慢性病治疗策略
Anticancer Res. 2020 Jan;40(1):1-7. doi: 10.21873/anticanres.13921.
9
Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis.结直肠癌肝转移的肝切除术：一项成本效益分析。
Ann Surg. 2000 Dec;232(6):763-76. doi: 10.1097/00000658-200012000-00005.
10
Impact of Hepatitis B Carrier Status on the Outcomes of Surgical Treatment of Colorectal Liver Metastases.乙肝携带者状态对结直肠癌肝转移手术治疗结局的影响
World J Surg. 2018 Aug;42(8):2642-2650. doi: 10.1007/s00268-018-4483-3.
引用本文的文献
1
Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance.肿瘤微环境异质性是前列腺癌进展和治疗抵抗的重要介导因素。
NPJ Precis Oncol. 2022 May 4;6(1):31. doi: 10.1038/s41698-022-00272-w.
本文引用的文献
1
Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial).mFOLFOX6 联合贝伐珠单抗对比 mFOLFOX6 联合西妥昔单抗一线治疗结直肠癌肝转移随机 II 期临床研究（ATOM 试验）。
Br J Cancer. 2019 Jul;121(3):222-229. doi: 10.1038/s41416-019-0518-2. Epub 2019 Jul 9.
2
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.日本结直肠癌学会（JSCCR）2019 年结直肠癌治疗指南。
Int J Clin Oncol. 2020 Jan;25(1):1-42. doi: 10.1007/s10147-019-01485-z. Epub 2019 Jun 15.
3
Recent advances in treatment for colorectal liver metastasis.结直肠癌肝转移治疗的最新进展
Ann Gastroenterol Surg. 2018 Apr 17;2(3):167-175. doi: 10.1002/ags3.12071. eCollection 2018 May.
4
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes.根据肿瘤位置而非侧别对结直肠癌进行分类突出了突变特征和共识分子亚型的连续性。
Clin Cancer Res. 2018 Mar 1;24(5):1062-1072. doi: 10.1158/1078-0432.CCR-17-2484. Epub 2017 Nov 27.
5
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.ESMO 共识指南：转移性结直肠癌患者的管理。
Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5.
6
Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases.结直肠癌肝转移初次肝切除术后连续复发进行重复切除的生存获益。
Surgery. 2016 Feb;159(2):632-40. doi: 10.1016/j.surg.2015.09.003. Epub 2015 Oct 21.
7
A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).一项关于mFOLFOX6联合贝伐单抗治疗不适于 upfront 切除的仅肝转移结直肠癌的多中心 II 期试验（TRICC0808） 。
Ann Surg Oncol. 2015 Mar;22(3):908-15. doi: 10.1245/s10434-014-4094-7. Epub 2014 Dec 3.
8
A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study.基于 LiverMetSurvey 的研究：对晚期结直肠癌肝转移同期序贯肝优先反转管理的生存分析。
Ann Surg. 2012 Nov;256(5):772-8; discussion 778-9. doi: 10.1097/SLA.0b013e3182734423.
9
Fate of metastatic foci after chemotherapy and usefulness of contrast-enhanced intraoperative ultrasonography to detect minute hepatic lesions.化疗后转移灶的命运和术中超声造影在检测微小肝病变中的作用。
J Hepatobiliary Pancreat Sci. 2012 Sep;19(5):509-14. doi: 10.1007/s00534-012-0510-1.
10
Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.右门静脉结扎联合原位劈裂诱导快速左外侧肝叶肥大，使小肝体积下 2 期扩大右半肝切除术成为可能。
Ann Surg. 2012 Mar;255(3):405-14. doi: 10.1097/SLA.0b013e31824856f5.
Zotero 插件